Medical therapies initiated on RA patients that participated in the microarray studies.

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/Medical_therapies_initiated_on_RA_patients_that_participated_in_the_microarray_studies_/10276532 数据链接链接失效反馈

官方服务：

资源简介：

Medical therapies initiated on RA patients that participated in the microarray studies.

创建时间：

2019-11-08

Additional file 3 of Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis

药物反应生物标志物

差异表达基因分析

Additional file 3. List of genes with higher and lower expression levels in EULAR good responders compared to non-responders.

Figshare2020-03-13 更新110

Available IPD datapackage for study 'A Multicenter Randomized Placebo-Controlled Phase II Study of the Human Anti-TNF Antibody D2E7 Administered as Subcutenous Injections in Rheumatoid Arthritis Patients Treated with Methotrexate.'

类风湿关节炎治疗反应

抗TNF治疗

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promot

DataCite Commons2025-01-06 更新60

Dataset from A Phase IIIb Open-label run-in Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety/Efficacy of Certolizumab Pegol Administered Concomitantly With Stable-dose Methotrexate in Patients With Active Rheumatoid Arthritis.

类风湿关节炎治疗反应

药物疗效评估

During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and 4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and 16. At Wk 18 p

NIAID Data Ecosystem30

Effects of bevacizumab (avastin) in mouse model of endometrial cancer

子宫内膜癌靶向治疗

药物反应生物标志物

Microarrays were used to determine the efficacy of bevacizumab (a monoclonal antibody against the vascular endothelial growth factor and its receptors.) on endometrial cancer cells. Endometrial cancer

NIAID Data Ecosystem70

Bulk RNAseq of primary CD34+ HSPCs in Myeloproliferative neoplasms patients receiving tamoxifen

骨髓增殖性肿瘤

药物反应生物标志物

TAMARIN study is a Phase II, multicenter, single arm A’herns design clinical trial assessing tamoxifen’s safety and activity in reducing molecular markers of disease burden in MPN.The primary outcome

NIAID Data Ecosystem40

Medical therapies initiated on RA patients that participated in the microarray studies.

资源简介：

相关数据集